Abiopharma

Publication date of the report for the first quarter of 2026 on 19.5.26

Appointment of Adv. Mor Fingerer as the Bank’s Chief Legal Counsel, subject to

Dormant shares – change in the number of shares

Self purchase/sale of securities

The subsidiary Ness (98%) in an agreement to purchase all holdings in Log-On Ltd. and Log-On’s subsidiary and sub-subsidiary for approximately NIS 164.5 million, details, subject to

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Register of shareholders, changes and share capital status – exercise of warrants (series 4) into shares

10x Genomics - 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments

Compass Pathways - Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments